Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[Consequently, new genes have emerged as breast cancer susceptibility genes, including rare germline mutations in high penetrant genes, such as TP53 and PTEN, and more frequent mutations in moderate penetrant genes, such as CHEK2, ATM and PALB2.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• assertion description "[Consequently, new genes have emerged as breast cancer susceptibility genes, including rare germline mutations in high penetrant genes, such as TP53 and PTEN, and more frequent mutations in moderate penetrant genes, such as CHEK2, ATM and PALB2.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Consequently, new genes have emerged as breast cancer susceptibility genes, including rare germline mutations in high penetrant genes, such as TP53 and PTEN, and more frequent mutations in moderate penetrant genes, such as CHEK2, ATM and PALB2.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP945337.RAbBsyOIy9PyGiebaMtM8OiAEzT-GbOsf_L0D5h45PxGA130_assertion description "[Consequently, new genes have emerged as breast cancer susceptibility genes, including rare germline mutations in high penetrant genes, such as TP53 and PTEN, and more frequent mutations in moderate penetrant genes, such as CHEK2, ATM and PALB2.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP945337.RAbBsyOIy9PyGiebaMtM8OiAEzT-GbOsf_L0D5h45PxGA130_provenance.
• assertion description "[Consequently, new genes have emerged as breast cancer susceptibility genes, including rare germline mutations in high penetrant genes, such as TP53 and PTEN, and more frequent mutations in moderate penetrant genes, such as CHEK2, ATM and PALB2.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Consequently, new genes have emerged as breast cancer susceptibility genes, including rare germline mutations in high penetrant genes, such as TP53 and PTEN, and more frequent mutations in moderate penetrant genes, such as CHEK2, ATM and PALB2.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Consequently, new genes have emerged as breast cancer susceptibility genes, including rare germline mutations in high penetrant genes, such as TP53 and PTEN, and more frequent mutations in moderate penetrant genes, such as CHEK2, ATM and PALB2.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Consequently, new genes have emerged as breast cancer susceptibility genes, including rare germline mutations in high penetrant genes, such as TP53 and PTEN, and more frequent mutations in moderate penetrant genes, such as CHEK2, ATM and PALB2.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Consequently, new genes have emerged as breast cancer susceptibility genes, including rare germline mutations in high penetrant genes, such as TP53 and PTEN, and more frequent mutations in moderate penetrant genes, such as CHEK2, ATM and PALB2.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Consequently, new genes have emerged as breast cancer susceptibility genes, including rare germline mutations in high penetrant genes, such as TP53 and PTEN, and more frequent mutations in moderate penetrant genes, such as CHEK2, ATM and PALB2.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP1244125.RAcAcMVgG6mlb-xBrO0qrz_LFTzIGb38b6FaguNks4e7Q130_assertion description "[Consequently, new genes have emerged as breast cancer susceptibility genes, including rare germline mutations in high penetrant genes, such as TP53 and PTEN, and more frequent mutations in moderate penetrant genes, such as CHEK2, ATM and PALB2.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1244125.RAcAcMVgG6mlb-xBrO0qrz_LFTzIGb38b6FaguNks4e7Q130_provenance.
• NP1244127.RASwAcJRS5GSAopaPA8tqgHdw96w09V7Zn2bat1lQ2M_s130_assertion description "[Consequently, new genes have emerged as breast cancer susceptibility genes, including rare germline mutations in high penetrant genes, such as TP53 and PTEN, and more frequent mutations in moderate penetrant genes, such as CHEK2, ATM and PALB2.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1244127.RASwAcJRS5GSAopaPA8tqgHdw96w09V7Zn2bat1lQ2M_s130_provenance.
• NP1244129.RAaY9th40aaKBZnNg2vV091G75k9w6kEvtNB0cCcsxVPY130_assertion description "[Consequently, new genes have emerged as breast cancer susceptibility genes, including rare germline mutations in high penetrant genes, such as TP53 and PTEN, and more frequent mutations in moderate penetrant genes, such as CHEK2, ATM and PALB2.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1244129.RAaY9th40aaKBZnNg2vV091G75k9w6kEvtNB0cCcsxVPY130_provenance.
• NP1244130.RAbYmqIOLKFXH6uhrH74Zy9MNANchQ9ZnRrD1ZrX1omMo130_assertion description "[Consequently, new genes have emerged as breast cancer susceptibility genes, including rare germline mutations in high penetrant genes, such as TP53 and PTEN, and more frequent mutations in moderate penetrant genes, such as CHEK2, ATM and PALB2.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1244130.RAbYmqIOLKFXH6uhrH74Zy9MNANchQ9ZnRrD1ZrX1omMo130_provenance.
• NP1244132.RAQGSbKi0eol2bOvylO1f5j36ZyA2JjoCDos-rpaMNc2M130_assertion description "[Consequently, new genes have emerged as breast cancer susceptibility genes, including rare germline mutations in high penetrant genes, such as TP53 and PTEN, and more frequent mutations in moderate penetrant genes, such as CHEK2, ATM and PALB2.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1244132.RAQGSbKi0eol2bOvylO1f5j36ZyA2JjoCDos-rpaMNc2M130_provenance.
• NP1244128.RADTbdMPgT9O0vVs82xGqHLQaZv8VQ_0kt9D1Fwah5-eQ130_assertion description "[Consequently, new genes have emerged as breast cancer susceptibility genes, including rare germline mutations in high penetrant genes, such as TP53 and PTEN, and more frequent mutations in moderate penetrant genes, such as CHEK2, ATM and PALB2.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1244128.RADTbdMPgT9O0vVs82xGqHLQaZv8VQ_0kt9D1Fwah5-eQ130_provenance.
• assertion description "[Consequently, new genes have emerged as breast cancer susceptibility genes, including rare germline mutations in high penetrant genes, such as TP53 and PTEN, and more frequent mutations in moderate penetrant genes, such as CHEK2, ATM and PALB2.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Consequently, new genes have emerged as breast cancer susceptibility genes, including rare germline mutations in high penetrant genes, such as TP53 and PTEN, and more frequent mutations in moderate penetrant genes, such as CHEK2, ATM and PALB2.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP654781.RADQNx80s1DRRQ61ZWqFym-gjCiz7G0hHDEaf3CUaOO3Q130_assertion description "[Consequently, new genes have emerged as breast cancer susceptibility genes, including rare germline mutations in high penetrant genes, such as TP53 and PTEN, and more frequent mutations in moderate penetrant genes, such as CHEK2, ATM and PALB2.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP654781.RADQNx80s1DRRQ61ZWqFym-gjCiz7G0hHDEaf3CUaOO3Q130_provenance.
• NP255006.RAB9sNZBglAKV5paFSY7zQPWT2sy-FAAFGXgnwwg73q1E130_assertion description "[Consequently, new genes have emerged as breast cancer susceptibility genes, including rare germline mutations in high penetrant genes, such as TP53 and PTEN, and more frequent mutations in moderate penetrant genes, such as CHEK2, ATM and PALB2.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP255006.RAB9sNZBglAKV5paFSY7zQPWT2sy-FAAFGXgnwwg73q1E130_provenance.
• NP255666.RABiEk1PKVfgcAXI3jPhFzmWUeAB7iKSvKFZgHlIm9RiY130_assertion description "[Consequently, new genes have emerged as breast cancer susceptibility genes, including rare germline mutations in high penetrant genes, such as TP53 and PTEN, and more frequent mutations in moderate penetrant genes, such as CHEK2, ATM and PALB2.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP255666.RABiEk1PKVfgcAXI3jPhFzmWUeAB7iKSvKFZgHlIm9RiY130_provenance.
• NP1244131.RAjXhYVIv2mMV3chq_4qhOHytqNfCgBu4Ta5jYJ4F7dEU130_assertion description "[Consequently, new genes have emerged as breast cancer susceptibility genes, including rare germline mutations in high penetrant genes, such as TP53 and PTEN, and more frequent mutations in moderate penetrant genes, such as CHEK2, ATM and PALB2.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1244131.RAjXhYVIv2mMV3chq_4qhOHytqNfCgBu4Ta5jYJ4F7dEU130_provenance.
• NP945430.RAvxIT5hA6NDD_ytFVnB4ZQuffw0I9zLF1DXHUQdkLxPk130_assertion description "[Consequently, new genes have emerged as breast cancer susceptibility genes, including rare germline mutations in high penetrant genes, such as TP53 and PTEN, and more frequent mutations in moderate penetrant genes, such as CHEK2, ATM and PALB2.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP945430.RAvxIT5hA6NDD_ytFVnB4ZQuffw0I9zLF1DXHUQdkLxPk130_provenance.
• NP862719.RAJySmmhYYYcfmz_BKz2Q8I5XMoDmxm3JLrbndPeWtU_o130_assertion description "[Consequently, new genes have emerged as breast cancer susceptibility genes, including rare germline mutations in high penetrant genes, such as TP53 and PTEN, and more frequent mutations in moderate penetrant genes, such as CHEK2, ATM and PALB2.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP862719.RAJySmmhYYYcfmz_BKz2Q8I5XMoDmxm3JLrbndPeWtU_o130_provenance.
• NP1244133.RAFIbPNLRHlHSi6YtuqlDqGABa8qbApG3p0u0C-gWNshs130_assertion description "[Consequently, new genes have emerged as breast cancer susceptibility genes, including rare germline mutations in high penetrant genes, such as TP53 and PTEN, and more frequent mutations in moderate penetrant genes, such as CHEK2, ATM and PALB2.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1244133.RAFIbPNLRHlHSi6YtuqlDqGABa8qbApG3p0u0C-gWNshs130_provenance.
• NP1244126.RAzJjB3AmAOoJn86XwqogQhmPZjn5U9l-aKizxWqqnjy4130_assertion description "[Consequently, new genes have emerged as breast cancer susceptibility genes, including rare germline mutations in high penetrant genes, such as TP53 and PTEN, and more frequent mutations in moderate penetrant genes, such as CHEK2, ATM and PALB2.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1244126.RAzJjB3AmAOoJn86XwqogQhmPZjn5U9l-aKizxWqqnjy4130_provenance.
• NP1244134.RA6_i3btpyO2SBpdxY66XQYolDREFxbayjhw6m8xeLGKg130_assertion description "[Consequently, new genes have emerged as breast cancer susceptibility genes, including rare germline mutations in high penetrant genes, such as TP53 and PTEN, and more frequent mutations in moderate penetrant genes, such as CHEK2, ATM and PALB2.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1244134.RA6_i3btpyO2SBpdxY66XQYolDREFxbayjhw6m8xeLGKg130_provenance.
• NP862968.RA5Ul-XUMJgtKTDt928Zs9L63IrrXNhmgUV1SX7g5NWYc130_assertion description "[Consequently, new genes have emerged as breast cancer susceptibility genes, including rare germline mutations in high penetrant genes, such as TP53 and PTEN, and more frequent mutations in moderate penetrant genes, such as CHEK2, ATM and PALB2.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP862968.RA5Ul-XUMJgtKTDt928Zs9L63IrrXNhmgUV1SX7g5NWYc130_provenance.